These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10632081)

  • 1. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
    Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
    J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
    Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
    Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane.
    Yamamoto A; Tanaka H; Okumura S; Shinsako K; Ito M; Yamashita M; Okada N; Fujita T; Muranishi S
    Biol Pharm Bull; 2001 Apr; 24(4):385-9. PubMed ID: 11305600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
    Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
    J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
    Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
    Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
    Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
    Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
    Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
    Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
    Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
    Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
    Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labrafac
    McCartney F; Caisse P; Dumont C; Brayden DJ
    Int J Pharm; 2024 Aug; 661():124353. PubMed ID: 38909926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
    Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
    Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of permeability enhancers on paracellular permeability of acyclovir.
    Ates M; Kaynak MS; Sahin S
    J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs.
    Yamamoto A; Tatsumi H; Maruyama M; Uchiyama T; Okada N; Fujita T
    J Pharmacol Exp Ther; 2001 Jan; 296(1):84-90. PubMed ID: 11123366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
    Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
    Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
    Zhang H; Huang X; Zhang Y; Gao Y
    Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.
    Okumura S; Fukuda Y; Takahashi K; Fujita T; Yamamoto A; Muranishi S
    Pharm Res; 1996 Aug; 13(8):1247-51. PubMed ID: 8865321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
    Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
    Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.
    Yamamoto A; Okumura S; Fukuda Y; Fukui M; Takahashi K; Muranishi S
    J Pharm Sci; 1997 Oct; 86(10):1144-7. PubMed ID: 9344172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
    Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
    J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.